InMed Pharmaceuticals Inc. (MTRI) KPIs and segments
Close on Nov 13, 2026Market cap $102.18MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive InMed Pharmaceuticals's business
InMed Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
InMed Pharmaceuticals's fiscal year ends June 30 — Q2 FY24 = CQ4 2023 (calendar quarter).
| Add to chart | Metric | Q2 FY24 CQ4 2023 | Q1 FY24 CQ3 2023 | Q2 FY23 CQ4 2022 | Q1 FY23 CQ3 2022 |
|---|---|---|---|---|---|
Earlier reporting (last reported 2023)2 | |||||
Earlier reporting (last reported 2023)2 | |||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-09-09.
See a number that looks wrong?